The impact of anti-phosphatidylserine/prothrombin antibodies on pregnancy outcomes in patients with unexplained recurrent implantation failure: a retrospective cohort study
Anti-phosphatidylserine/prothrombin antibody (aPS/PT) positivity may be a risk factor for increased miscarriage rates in patients with unexplained recurrent implantation failure.
Authors
- J F Zhang
- Jing Shi
- Jiansuo Zhou
- Nan Yang
- Qiong Liu
- Yang Wang
- Haiyan Wang
- Jie Zhao
- Donglin Han
Institutions
- Peking University (CN)
- Ministry of Education (RO)
- National Blood Transfusion Service (NG)
- National Clinical Research (US)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-21
- DOI
- https://doi.org/10.3389/fimmu.2026.1731905
- Primary Topic
- Reproductive System and Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Peking University
- Peking University Third Hospital